by Peter Ciszewski | Jan 28, 2021
Auris Huen, MD, PharmD, MD Anderson Cancer Center, Department of Dermatology discusses a multidisciplinary approach to treating cutaneous T-cell lymphoma (CTCL). Although treatment of early-stage CTCL is often managed primarily by dermatologists, advanced disease is...
by Peter Ciszewski | Jan 27, 2021
Paul Orchard, MD, from the University of Minnesota Medical School, discusses the team approach needed to care for a person with mucopolysaccharidosis I (MPS I). MPS I is a rare lysosomal storage disorder due to the reduced function of the enzyme...
by Peter Ciszewski | Jan 26, 2021
Jorge Cortes, MD, Director of the Georgia Cancer Center discusses the newly approved dosing strategy for ponatinib to treat chronic myeloid leukemia (CML). More specifically, the US Food and Drug Administration (FDA) has approved a supplemental New Drug...
by Peter Ciszewski | Jan 26, 2021
Gina Glass, Executive Director and Founder of Dreamsickle Kids Foundation, discusses the unique difficulties of caring for someone with sickle cell disease. Sickle cell disease, as described by the NIH, is an inherited blood disorder. Early symptoms usually...
by Peter Ciszewski | Jan 26, 2021
Susan Samson, MD, PhD discusses how to define treatment success when caring for patients with acromegaly. Acromegaly is a rare endocrine disorder usually caused by a benign pituitary tumor and is characterized by excess production of growth hormone and insulin-like...
